Join our Business Development Manager Personal Care & Pharma, Ioana Iorga, our Group Leader Microbiomics, Michiel Wels, and our Senior Project Manager Fermentation, Bart Smit, at the Microbiome Movement Drug Development 2018 in Boston from the 20th till the 22nd of June 2018!
Michiel Wels will give a presentation on the first day of the event at 1.40 P.M., entitled ‘Genome based comparison and interpretation for the development of microbiome-based thereapeutic products‘, during the session ‘Early stage clinical trial trial design & development‘. He will discuss the following topics:
- Development of potent probiotics and LBP’s require understanding of mode of action.
- Further development of new therapeutics do not only require functional strains, but also strains that are safe and manufacturable.
- Genomics research on microbiome strain collections are a good first step in identifying new high potential strains.
NIZO is program partner of the Microbiome Movement Drug Development 2018. Join us to this event, as the industry unites to define future trends. From discovery and clinical development to future manufacturing and commercialization challenges (and everything in between) discover the solutions and partners you need to successfully accelerate your translation microbiome research into meaningful therapeutic development.